Market Overview

Evogene Tackles Corn Crop Fungal Diseases With Bayer

Evogene Tackles Corn Crop Fungal Diseases With Bayer

Evogene Ltd. (NASDAQ: EVGN) is amending its collaboration with Bayer AG (OTC: BAYRY)'s crop science division to identify genome editing targets for evaluation against a broad range of corn diseases.

The collaboration aims to develop improved corn seeds with resistance to fungal diseases.

Evogene said it will use its computational predictive biology platform to identify required edits to improve disease resistance in corn.

The overall annual value loss from corn diseases in the U.S. alone is estimated at close to $7 billion, according to Evogene. 

Evogene shares were trading up 3.90% at $1.60 in Tuesday’s pre-market session.

Related Links:

JPMorgan Q2 Earnings Beat Estimates

Johnson & Johnson Trades Higher On Q2 Earnings Beat


Related Articles (BAYRY + EVGN)

View Comments and Join the Discussion!

Posted-In: Biotech News General Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at